Adempa Tablet 10 mg contains Empagliflozin 10 mg, an oral antidiabetic medication indicated for the management of type 2 diabetes mellitus. It belongs to the sodium-glucose co-transporter 2 (SGLT2) inhibitor class, which works by lowering blood glucose levels through increased urinary glucose excretion. Adempa 10 mg is an effective option for patients who require improved glycemic control alongside diet, exercise, and regular monitoring.
Type 2 diabetes is often associated with insulin resistance and impaired glucose metabolism. Adempa offers an insulin-independent mechanism of action, making it suitable for use alone or in combination with other oral antidiabetic medications or insulin.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Empagliflozin 10 mg
Empagliflozin works by selectively inhibiting the SGLT2 protein in the kidneys. Normally, this protein is responsible for reabsorbing glucose back into the bloodstream from the urine. By blocking SGLT2, Empagliflozin reduces glucose reabsorption and promotes the elimination of excess glucose through urine.
This results in:
Lower fasting and post-meal blood glucose levels
Reduction in HbA1c levels
Mild diuretic effect that may help reduce blood pressure
Caloric loss that may support modest weight reduction
Because it does not stimulate insulin secretion, the risk of hypoglycemia is low when used as monotherapy.
Adempa Tablet 10 mg is indicated for:
Management of Type 2 Diabetes Mellitus
Patients inadequately controlled with diet and exercise
Use as monotherapy or combination therapy with metformin, sulfonylureas, DPP-4 inhibitors, or insulin
Reduction of cardiovascular risk in appropriate patients with type 2 diabetes and established cardiovascular disease, as advised by a healthcare professional
Effective Blood Sugar Control: Helps reduce HbA1c and fasting glucose levels.
Weight Management Support: May assist in modest weight loss.
Cardiovascular Protection: Shown to reduce cardiovascular events in eligible patients.
Blood Pressure Reduction: Mild diuretic action may support blood pressure control.
Low Hypoglycemia Risk: Especially when not combined with insulin or insulin secretagogues.
The recommended starting dose is typically 10 mg once daily, taken in the morning, with or without food. Dosage adjustments should be made by a healthcare provider based on individual response and kidney function.
Patients are advised to maintain adequate hydration during therapy. Regular monitoring of blood glucose, HbA1c, and renal function is recommended.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Not suitable for Type 1 diabetes or diabetic ketoacidosis.
Use cautiously in patients with renal impairment.
May increase the risk of urinary tract infections and genital infections.
Increased urination and mild dehydration may occur.
Rare cases of ketoacidosis have been reported; seek immediate medical attention if symptoms such as nausea, vomiting, abdominal pain, or shortness of breath develop.
Adempa Tablet 10 mg should be used under medical supervision. Patients should inform their healthcare provider about any other medications and pre-existing medical conditions before starting therapy.
Login Or Registerto submit your questions to seller
No none asked to seller yet